Integrated Care News by CFHA
MAY 19, 2025
MBC is a clinical process that includes repeated measurement to monitor treatment progress and to inform collaborative treatment planning over the course of care. (1) This position statement is intended to clarify and inform all members, partners, and the public regarding CFHA’s organizational stance on MBC. What is MBC?
FDA Law Blog
DECEMBER 4, 2023
DEA has interpreted pharmacists’ corresponding responsibility as prohibiting the filling of a prescription where the pharmacist or pharmacy “knows or has reason to know” that the prescription is invalid. Holiday CVS, L.L.C. d/b/a CVS/Pharmacy, Nos. 219 and 5195; Decision and Order , 77 Fed. 62,316, 62,342 (Oct.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 4, 2024
Since the enactment of the Food and Drug Administration Safety and Innovation Act (FDASIA) in 2012, manufacturers have been required to notify FDA of product changes affecting certain finished drugs and biological products. API and its source and any alternative sources; associated medical devices), and expected duration of the interruption.
Pamela Wible MD
JUNE 20, 2025
Since 2012, I’ve spoken to thousands of suicidal doctors—even published a book of physician suicide letters. Solving our crisis requires a definitive diagnosis and treatment plan. Doctors have the highest suicide rate of any profession. Not burnout. Now is the time for brutal truth—and action.
The Clinical Problem Solvers
NOVEMBER 16, 2020
Acknowledging this truth highlights the necessity of mitigating the harms of racism as part of any comprehensive treatment plan. 2012 Sep;53(3):279-95. This is done on an individual level, by offering existing support and resources, as well as on a systemic level through advocacy. link] Wilkerson, I. Random House. The New Press.
Expert insights. Personalized for you.
100 
Let's personalize your content